COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons

Sulaiman, Sahabi Kabir; Musa, Muhammad Sale; Tsiga-Ahmed, Fatimah I.; Dayyab, Farouq Muhammad; Sulaiman, Abdulwahab Kabir; Dabo, Bashir; Ahmad, Saidu Idris; Haruna, Salisu Abubakar; Zubair, Abdullahi Abdurrahman; Hussein, Aminu; Usman, Sadiya; Wada, Jummai Usman; Ayodele, Ayoola Yekeen; Ali, Muhammed Wulgo; Bello, Islam Umar; Isa, Alhaji Muhammad; Ali, Fatima Shettima; Ismail, Abubakar Garba; Makama, Bello Tijjani; Abdulkadir, Abdulkadir Dalhatu; Abdulnasir, Najib Jamal; Gambo, Bashir Zakar; Mustapha, Mukhtar Usman; Mohammed, Mustapha; Ibrahim, Gambo; Dogo, Hadiza Adamu; Abubakar, Fatima Ishaq; kurugu, Yakubu; Yusufari, Garba Auwal; Saleh, Salamatu; Yakubu, Abubakar; Sulaiman, Saeed; Bako, Abdulaziz

doi:10.1016/j.vaccine.2023.02.056

Cited by 12 publications

(7 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Notably, the study conducted at Woldia Comprehensive Hospital found that 66.7% [ 31 ] of the participants had good knowledge on COVID-19 vaccination. Our finding lower in the study conducted in Debre tabor Comprehensive specialized hospital(57.7%) [ 36 ], Addis Ababa health worker(60.3%) [ 50 ], overall in Ethiopia(64.4%) [ 34 ], Nigeria(57.72%) [ 51 ], Democratic republic Congo(72.3%) [ 52 ], and Portugal(59%) [ 53 ].This variation in vaccination rates could be attributed to differences in the study population and the area of the study. For example, in the study conducted on people living with HIV, they may have had more frequent contact with healthcare providers who could have provided counseling on COVID-19 vaccination.…”

Section: Discussionmentioning

confidence: 58%

Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study

Alie,

Abebe,

Negesse

et al. 2024

Heliyon

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 58%

Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study

Alie,

Abebe,

Negesse

et al. 2024

Heliyon

View full text Add to dashboard Cite

“…Moreover, despite that several studies showing that COVID-19 vaccination is effective in preventing these adverse outcomes [ 14 – 17 ], vaccine hesitancy remains a global problem [ 18 ], particularly among higher-risk populations such as PLHIV. Concerns about vaccine safety have been identified as a primary factor contributing to COVID-19 vaccine hesitancy among this population [ 19 , 20 ].…”

Section: Introductionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on people living with HIV: a cross-sectional study in Caracas, Venezuela

Forero-Peña,

Carrión-Nessi,

Forero-Peña

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted multiple health services, including human immunodeficiency virus (HIV) testing, care, and treatment services, jeopardizing the achievement of the Joint United Nations Programme on HIV/AIDS 90-90-90 global target. While there are limited studies assessing the impact of the COVID-19 pandemic on people living with HIV (PLHIV) in Latin America, there are none, to our knowledge, in Venezuela. This study aims to assess the impact of the COVID-19 pandemic among PLHIV seen at the outpatient clinic of a reference hospital in Venezuela. Methods We conducted a cross-sectional study among PLHIV aged 18 years and over seen at the Infectious Diseases Department of the University Hospital of Caracas, Venezuela between March 2021 and February 2022. Results A total of 238 PLHIV were included in the study. The median age was 43 (IQR 31–55) years, and the majority were male (68.9%). Most patients (88.2%, n = 210) came for routine check-ups, while 28 (11.3%) were newly diagnosed. The majority of patients (96.1%) were on antiretroviral therapy (ART), but only 67.8% had a viral load test, with almost all (95.6%) being undetectable. Among those who attended regular appointments, 11.9% reported missing at least one medical consultation, and 3.3% reported an interruption in their ART refill. More than half of the patients (55.5%) had received at least one dose of the COVID-19 vaccine, while the rest expressed hesitancy to get vaccinated. Most patients with COVID-19 vaccine hesitancy were male (65.1%), younger than 44 years (57.5%), employed (47.2%), and had been diagnosed with HIV for less than one year (33%). However, no statistically significant differences were found between vaccinated patients and those with COVID-19 vaccine hesitancy. Older age was a risk factor for missing consultations, while not having an alcoholic habit was identified as a protective factor against missing consultations. Conclusion This study found that the COVID-19 pandemic had a limited impact on adherence to medical consultations and interruptions in ART among PLHIV seen at the University Hospital of Caracas, Venezuela.

show abstract

“…Studies also indicate that COVID-19 vaccine hesitancy (defined by the World Health Organization as the delay in acceptance or refusal of vaccination despite the availability of vaccination services [7]) is higher among this population and that factors influencing vaccine hesitancy are different for PLWH compared to HIV-negative individuals. Factors contributing to COVID-19 vaccine hesitancy among PLWH globally include perceived risks [8,9], safety concerns [10][11][12][13], distrust in vaccine information sources, doubts about COVID-19 existence and low-risk perception [10,14]. The study conducted among PLWH in Southwest Ethiopia indicated that the odds of intention to take the COVID-19 vaccine were 4.1 times higher among those participants who had good knowledge of COVID-19 practice compared with those who had poor knowledge [15].…”

Section: Introductionmentioning

confidence: 99%

HIV stigma and other barriers to COVID-19 vaccine uptake among Georgian people living with HIV/AIDS: A mixed-methods study

Zurashvili,

Chakhaia,

King

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

We conducted a study in Georgia to examine behavioral insights and barriers to COVID-19 vaccine uptake among people living with HIV (PLWH). Between December 2021-July 2022, we collected quantitative data to evaluate participants’ demographics, COVID-19 knowledge, attitude, perception, and HIV stigma as potential covariates for being vaccinated against COVID-19. We conducted a multivariate analysis to define the factors independently associated with COVID-19 vaccination among PLWH. We collected qualitative data to explore individual experiences of their positive or negative choices, main barriers, HIV stigma, and preferences for receiving vaccination. Of the total 85 participants of the study, 52.9% were vaccinated; 61.2% had concerns with the disclosure of HIV status at the vaccination site. Those who believed they would have a severe form of COVID-19 were more likely to be vaccinated (OR = 23.8; 95% CI: 5.1–111.7). The association stayed significant after adjusting for sex, age, education level, living area, health care providers’ unfriendly attitudes, and their fear of disclosing HIV status at vaccination places. Based on the qualitative study, status disclosure was a significant barrier to receiving care; therefore, PLWH prefer to receive COVID-19 vaccination integrated in HIV services. Conclusions: In this study, around half of the participants were not vaccinated against COVID-19. The main reasons for not being vaccinated included stigma, misleading health beliefs, and low awareness about COVID-19. An integrated service delivery model may improve vaccination uptake among PLWH in Georgia.

show abstract

COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons

Cited by 12 publications

References 50 publications

Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study

Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study

The impact of the COVID-19 pandemic on people living with HIV: a cross-sectional study in Caracas, Venezuela

HIV stigma and other barriers to COVID-19 vaccine uptake among Georgian people living with HIV/AIDS: A mixed-methods study

Contact Info

Product

Resources

About